Tomorrow9 events
To consider and approve the proposal for migration of listing/trading of equity shares from BSE SME platform to Main Board of Bombay Stock Exchange and National Stock Exchange of India Limited.
To consider, approve and take on record the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2026.
To consider and approve the audited financial results for the quarter and year ended March 31, 2026. Also, to consider the proposal for recommendation of final dividend for FY 2025-26.
To consider and approve financial results and statements for the quarter and financial year ended March 31, 2026. Also, to consider and approve raising of funds via debt instruments and qualified institutions placement, and convening the 33rd Annual General Meeting.
To consider and approve the Audited Financial Results for the fourth quarter and financial year ending March 31, 2026, and to consider and recommend dividend on equity shares.
To consider and approve audited financial results for the quarter and financial year ended on 31st March 2026. Also, to raise funds through preferential issue of shares/warrants and alter various clauses of the Memorandum of Association.
To consider and approve audited financial results for the financial year ended March 31, 2025, and to approve the date and time for the adjourned 56th Annual General Meeting.
To consider and approve the audited financial results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2026.
To consider and approve the allotment of equity shares on a preferential basis, following in-principle approval from BSE.
Tue, 21 Apr8 events
To consider and approve the audited financial results for the quarter and year ended 31 March 2026.
The Board will consider and approve the appointment of an Additional Director and amendments to the Memorandum of Association for business diversification. It will also approve the Notice of Postal Ballot, fix the cut-off date, and appoint a scrutinizer for the postal ballot process.
To consider, approve and take on record the Audited Financial Results for the 4th quarter and Financial year ended 31st March, 2026. The board may also consider and recommend Final Dividend for FY 2025-26.
To consider and approve the declaration of 2nd Interim Dividend for the financial year 2025-26.
To consider and approve the audited standalone and consolidated financial results and recommend dividend for the financial year ended March 31, 2026.
To consider and approve the Audited Financial Results for the fourth quarter and year ended 31st March, 2026.
To consider and approve audited financial results for the financial year ended March 31, 2026, and to recommend dividend.
To consider and approve the annual audited standalone and consolidated financial results for the fourth quarter and financial year ended March 31, 2026. Also, to consider and recommend final dividend and discuss matters relating to the ensuing Annual General Meeting.
To consider and approve audited financial results for the quarter and year ended March 31, 2026. The Board may also consider recommendation of final dividend.
To consider increasing the authorized share capital and approve a material related party transaction for revision in project cost.
To consider and approve the audited financial results for the quarter and financial year ended 31 March 2026.
To consider and approve financial results for the quarter and year ended March 31, 2026, declare distributions to unitholders, and raise debt.
To consider and approve Audited Financial Results for the 4th quarter and financial year ended March 31, 2026, and to consider and recommend Final Dividend, if any.
To consider and approve the Audited Financial Results for the Quarter and Financial Year ended March 31, 2026, and to consider recommending Dividend, if any.
To consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider the recommendation of dividend.
To consider and approve the unaudited (standalone & consolidated) financial results for the quarter and nine months ended 31st March, 2026.
To consider and approve standalone and consolidated audited financial results for the quarter and financial year ended March 31, 2026, and to consider recommendation of final dividend.
To take on record and approve the certificate issued by M/s. PAMS & Associates, Statutory Auditors, pursuant to Regulation 45(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.
To consider increasing the authorized share capital and altering the capital and object clauses of the Memorandum of Association.